Concepedia

Multiple daily doses of acetyl‐salicylic acid (ASA) overcome reduced platelet response to once‐daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial

Jeremy S. Paikin, J. Hirsh, J S Ginsberg, Jeffrey I. Weitz, Noel Chan, Richard Whitlock, Guillaume Paré, Marilyn Johnston, John W. Eikelboom

Journal of Thrombosis and Haemostasis · 2014 · 33 citations · 23 references

DOIFull text

Open access

Concepts

References

23

Efficacy and Safety of Edifoligide, an E2F Transcription Factor Decoy, for Prevention of Vein Graft Failure Following Coronary Artery Bypass Graft Surgery

JAMA · 2005 · 659 citations

, , +13

Inhibition of platelet prostaglandin synthetase by oral aspirin.

John W. Burch, N Stanford, Philip W. Majerus · Journal of Clinical Investigation · 1978 · 555 citations · Full text

, , +14

Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study.

Steven Goldman, Jack G. Copeland, Thomas Moritz et al. · Circulation · 1988 · 431 citations

, , +11

Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.

Steven Goldman, Jack G. Copeland, Thomas Moritz et al. · Circulation · 1989 · 294 citations · Full text

, , +14

Functional and Biochemical Evaluation of Platelet Aspirin Resistance After Coronary Artery Bypass Surgery

N. Zimmermann, A. Wenk, U. Kim et al. · Circulation · 2003 · 291 citations · Full text

, , +17